Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Emily Mulvihill"'
Autor:
Elizabeth A. Szamreta, Emily Mulvihill, Katherine Aguinaga, Kaitlan Amos, Heather Zannit, Ritu Salani
Publikováno v:
Gynecologic Oncology Reports, Vol 51, Iss , Pp 101321- (2024)
Objective: This study aimed to identify the information needs and factors for making informed treatment decisions among a diverse group of locally advanced cervical cancer (LACC) patients. Methods: Semi-structured interviews were conducted with LACC
Externí odkaz:
https://doaj.org/article/7b7ef65a3ec44f93b8f4fde1f99bd341
Autor:
Todd J. Schwedt, Ashley Martin, Steven Kymes, Brian Talon, Xin Ying Lee, Roger Cady, Divya Asher, Meghana Karnik‐Henry, Emily Mulvihill, Dawn Bates, Kathleen Beusterien
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:484-493
Publikováno v:
Journal of the American Institute for Conservation. :1-8
Autor:
Nina Shah, Elizabeth S. Mearns, Sean Carey, Emily Mulvihill, Sheri A. McClerklin, Karen Thomson, Jennifer M. Ahlstrom, Allicia Girvan, R. Frank Cornell, Michael Nixon
Publikováno v:
Blood. 140:12534-12536
Autor:
Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Emily Mulvihill, Reshma Shinde, Kimmie McLaurin
Publikováno v:
Future Oncology. 18:1927-1941
The goal of this study was to understand the preferences of patients and physicians for the benefits and risks associated with the treatment of advanced breast cancer that expresses normal amounts of the HER2 protein (termed as HER2 negative). Respon
Autor:
Todd J. Schwedt, Ashley Martin, Steven Kymes, Brian Talon, Xin Ying Lee, Roger Cady, Divya Asher, Meghana Karnik-Henry, Emily Mulvihill, Dawn Bates, Kathleen Beusterien
Publikováno v:
Tuesday, April 25.
Autor:
Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Stephanie Ritz, Emily Mulvihill, Matthew Monberg, Elizabeth A Szamreta, Suvina Amin, Kimmie McLaurin
Publikováno v:
Future Oncology. 18:491-503
Plain language summary Maintenance therapy is a treatment option intended to keep ovarian cancer from coming back or getting worse for as long as possible after responding to chemotherapy. PARP inhibitors are a new type of maintenance therapy for ova
Autor:
Michael Wallington, Xavier Guillaume, Emily Mulvihill, Graceanne R Wayser, Vandana Kaul, Claire Graziani-Taugeron, Mina Shahkarami, Kellie J. Ryan
Publikováno v:
Blood. 140:10810-10811
Autor:
Candice Yong, Ranee Mehra, Kelly Clapp, Brian S. Seal, Ion Cotarla, M. Janelle Cambron-Mellott, Emily Mulvihill, Oliver Will, Martine C Maculaitis
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-106
Autor:
Candice Yong, Brian Seal, M. Janelle Cambron-Mellott, Oliver Will, Martine C. Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, Ranee Mehra
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-112